Evidence map›Paper›PMID 40650213›Full record

ReviewInternational journal of molecular sciences2025

Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective.

Liudas Vincentas Sinkevicius, Sandra Sakalauskaite, Maris Bukovskis, Margus Lõokene, Vahur Valvere, Brigita Gradauskiene, Margus Viigimaa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liudas Vincentas SinkeviciusDepartment of Health Psychology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.
Sandra SakalauskaiteLaboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.ORCID 0000-0002-9261-4805
Maris BukovskisFaculty of Medicine, University of Latvia, 1586 Ryga, Latvia.
Margus LõokeneToompargi Vaimse Tervise Keskus, 10149 Tallinn, Estonia.
Vahur ValvereClinic of Oncology and Hematology, North Estonia Medical Centre, 13419 Tallin, Estonia.
Brigita GradauskieneDepartment of Immunology and Allergology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.ORCID 0000-0001-5086-8893
Margus ViigimaaNorth Estonia Medical Centre, Tallinn University of Technology, 13419 Tallinn, Estonia.ORCID 0000-0001-5575-5978

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statistical data demonstrate a concurrent rise in smoking prevalence and mental disorders, such as depression and anxiety, which may be attributed to contemporary lifestyle factors, including social media and recent global events. This indicates a potential correlation between these trends, as individuals with mental disorders may engage in smoking as a form of self-medication to alleviate anxiety. However, smoking is harmful and increases the risk of many diseases. Therefore, smoking cessation strategies are increasingly being considered. Nicotine is a naturally produced alkaloid in plants that makes smoking so addictive. Unfortunately, the public's lack of understanding of the effects of nicotine leads to misleading claims in the public and media about its biological effects. Thus, current narrative literature review is focused on the examination of the biological effects of organic nicotine from various angles, considering the psychological aspects of addiction and the immune system. Analysis of recent data showed that nicotine not only causes addiction but also has therapeutic benefits in certain diseases (depression, anxiety, schizophrenia) and has anti-inflammatory properties (autoimmunity, neurodegenerative diseases), and a deeper understanding and a broader approach to its effects is needed.

Indexed as

NicotineAnimalsAnxietyHumansPsychoneuroimmunologySmokingTobacco Use DisorderNicotineaddictionautoimmunitycancercardiovascular diseasescytokinesharm reductioninflammationneurodegenerative diseasesnicotinic acetylcholine receptorssmoking

Identifiers

PMID40650213
PMCPMC12250386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.